NY, July 20, 2016 /PRNewswire/ — The worldwide in-vitro toxicology screening marketplace is likely to USD 27.36 million by 2021 from USD 14.15 million in 2016, in a CAGR of 14.1PERCENT between 2016 and 2021. By-product, the marketplace contains solutions and assays, reagents. Centered on toxicity endpoints assessments, the marketplace is segmented into body toxicity toxicity, carcinogenicity skin sensitization & amp genotoxicity and toxicity. The systemic poisoning section may contain the biggest share of the in-vitro toxicology screening toxicity endpoints & assessments marketplace in 2016.
Contact Clare: email@example.com
Intl: +1 339-368-6001